These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18002471)

  • 1. The relationship between electrovestibulography and Parkinson's disease severity.
    Shoushtarian M; Lithgow B
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():2377-80. PubMed ID: 18002471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Parkinson's disease using electrovestibulography.
    Dastgheib ZA; Lithgow B; Moussavi Z
    Med Biol Eng Comput; 2012 May; 50(5):483-91. PubMed ID: 22399163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrovestibulography: the "DC" potential used to separate Meniere's disease and Benign Paroxysmal Positional Vertigo.
    Garrett A; Heibert D; Lithgow B
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():2381-4. PubMed ID: 18002472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vestibular spontaneous response as a potential signature for Parkinson's disease.
    Dastgheib ZA; Lithgow B; Moussavi Z
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():3704-7. PubMed ID: 23366732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of fractal dimension on vestibular response signals for diagnosis of Parkinson's disease.
    Dastgheib ZA; Lithgow B; Moussavi Z
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():7892-5. PubMed ID: 22256170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease. Clinical and electrophysiological evaluation.
    Al-Bunyan MA
    Saudi Med J; 2000 Jan; 21(1):72-5. PubMed ID: 11533754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perseveration for novel stimuli in Parkinson's disease: an evaluation based on event-related potentials topography.
    Hozumi A; Hirata K; Tanaka H; Yamazaki K
    Mov Disord; 2000 Sep; 15(5):835-42. PubMed ID: 11009188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: disturbed vestibular function and levodopa.
    Lithgow BJ; Shoushtarian M
    J Neurol Sci; 2015; 353(1-2):49-58. PubMed ID: 25899315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease.
    Singh A; Mewes K; Gross RE; DeLong MR; Obeso JA; Papa SM
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9629-34. PubMed ID: 27503874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neural network model of Parkinson's disease bradykinesia.
    Cutsuridis V; Perantonis S
    Neural Netw; 2006 May; 19(4):354-74. PubMed ID: 16359844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional segregation of basal ganglia pathways in Parkinson's disease.
    Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
    Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Event-related potentials, reaction time, and cognitive state in patients with Parkinson's disease.
    Hayashi R; Hanyu N; Shindo M; Tamaru F; Yanagisawa N
    Adv Neurol; 1993; 60():429-33. PubMed ID: 8420167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired temporal discrimination in Parkinson's disease: temporal processing of brief durations as an indicator of degeneration of dopaminergic neurons in the basal ganglia.
    Rammsayer T; Classen W
    Int J Neurosci; 1997 Sep; 91(1-2):45-55. PubMed ID: 9394214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits.
    Obeso JA; Rodriguez-Oroz M; Marin C; Alonso F; Zamarbide I; Lanciego JL; Rodriguez-Diaz M
    Neurology; 2004 Jan; 62(1 Suppl 1):S17-30. PubMed ID: 14718677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillatory activity in the cortico-basal ganglia-thalamic neural circuits in Parkinson's disease.
    Singh A
    Eur J Neurosci; 2018 Oct; 48(8):2869-2878. PubMed ID: 29381817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perception of emotional speech in Parkinson's disease.
    Schröder C; Möbes J; Schütze M; Szymanowski F; Nager W; Bangert M; Münte TF; Dengler R
    Mov Disord; 2006 Oct; 21(10):1774-8. PubMed ID: 16830324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptors set the pattern of activity generated in subthalamic neurons.
    Baufreton J; Zhu ZT; Garret M; Bioulac B; Johnson SW; Taupignon AI
    FASEB J; 2005 Nov; 19(13):1771-7. PubMed ID: 16260646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.